Učitavanje...
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
Purpose: We aimed to investigate the expression of FOXM1 and to determine the relationships between FOXM1 expression and clinicopathologic characteristics in patients with PCa. Furthermore, we reconfirmed the prognostic impact of FOXM1 in different cohorts using already published data. Patients and...
Spremljeno u:
| Izdano u: | J Cancer |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ivyspring International Publisher
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360432/ https://ncbi.nlm.nih.gov/pubmed/30719174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.28099 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|